Jpmorgan Chase & Co »

Context Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $25 23 1.13
2023-09-30 $24 16 1.50

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Context Therapeutics

Opaleye Management
Vanguard Group
HighTower Advisors
Clear Harbor Asset Management
Susquehanna International
Sheets Smith Wealth Management
Citadel Advisors
UBS Group
Advisor Group Holdings
Retirement Group
Wells Fargo & Company
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Context Therapeutics